CRNX - Crinetics Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2020)Next Qtr. (Sep 2020)Current Year (2020)Next Year (2021)
No. of Analysts5556
Avg. Estimate-0.57-0.59-2.47-2.7
Low Estimate-0.72-0.75-2.96-3.46
High Estimate-0.45-0.44-2.05-2.25
Year Ago EPS-0.51-0.6-2.09-2.47
Revenue EstimateCurrent Qtr. (Jun 2020)Next Qtr. (Sep 2020)Current Year (2020)Next Year (2021)
No. of Analysts5546
Avg. EstimateN/AN/A40kN/A
Low EstimateN/AN/AN/AN/A
High EstimateN/AN/A70kN/A
Year Ago Sales150k505k1.19M40k
Sales Growth (year/est)N/AN/A-96.60%N/A
Earnings History2019-06-292019-09-292019-12-302020-03-30
EPS Est.-0.46-0.57-0.68-0.63
EPS Actual-0.51-0.6-0.6-0.71
Difference-0.05-0.030.08-0.08
Surprise %-10.90%-5.30%11.80%-12.70%
EPS TrendCurrent Qtr. (Jun 2020)Next Qtr. (Sep 2020)Current Year (2020)Next Year (2021)
Current Estimate-0.57-0.59-2.47-2.7
7 Days Ago-0.57-0.59-2.47-2.7
30 Days Ago-0.57-0.59-2.47-2.7
60 Days Ago-0.67-0.71-2.78-3.03
90 Days Ago-0.67-0.71-2.78-3.03
EPS RevisionsCurrent Qtr. (Jun 2020)Next Qtr. (Sep 2020)Current Year (2020)Next Year (2021)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesCRNXIndustrySector(s)S&P 500
Current Qtr.-11.80%N/AN/AN/A
Next Qtr.1.70%N/AN/AN/A
Current Year-18.20%N/AN/AN/A
Next Year-9.30%N/AN/AN/A
Next 5 Years (per annum)N/AN/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A